Impact of timing of adjuvant chemotherapy following radical cystectomy for bladder cancer on patient survival.

Date publication

juillet 2020

Journal

Urologic oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr LADOIRE Sylvain

Tous les auteurs :
Grunewald CM, Henn A, Galsky MD, Plimack ER, Harshman LC, Yu EY, Crabb SJ, Pal SK, Alva AS, Powles T, De Giorgi U, Agarwal N, Bamias A, Ladoire S, Necchi A, Vaishampayan UN, Sternberg CN, Bellmunt J, Baniel J, Niegisch G

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/32660788

Résumé

Trials of adjuvant chemotherapy following radical cystectomy generally require chemotherapy to start within 90 days postoperatively. However, it is unclear, whether the interval between surgery and start of adjuvant therapy (S-AC-interval) impacts the oncological outcome.

Mots clés

Adjuvant chemotherapy, Locally advanced bladder cancer, Muscle invasive bladder cancer, RISC data base

Référence

Urol. Oncol.. 2020 Jul 10;: